Kyaw, Tin <br/><br/>
BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice.  [electronic resource] 

 -  PloS one  2013 
 - e60430 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0060430  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Antigens, CD--genetics<br/>Apolipoproteins E--deficiency<br/>Atherosclerosis--complications<br/>B-Cell Activation Factor Receptor--antagonists & inhibitors<br/>B-Lymphocyte Subsets--drug effects<br/>Cytokines--biosynthesis<br/>Diet, High-Fat<br/>Disease Progression<br/>Hyperlipidemias--complications<br/>Lymphocyte Depletion<br/>Male<br/>Mice<br/>Mice, Knockout<br/>Spleen--drug effects